Indications and uses
Temporarily relieves minor pain associated with: arthritis, simple backache, bursitis, tendonitis, muscle strains, sprains & bruises.
Temporarily relieves minor pain associated with: arthritis, simple backache, bursitis, tendonitis, muscle strains, sprains & bruises.
❏ adults: apply patch to affected area for a maximum of 12 hours. Do not use more than 1 patch every 24 hours. ❏ children: consult your physician ❏ remove protective film, gently apply to affected area.
Drug Facts
| Active Ingredients | Purpose |
|---|---|
| Lidocaine 3.99% | Topical analgesic |
| Menthol 1% | Topical analgesic |
Temporarily relieves minor pain associated with: arthritis, simple backache, bursitis, tendonitis, muscle strains, sprains & bruises.
For external use only.
Do not use if you are allergic or sensitive to lidocaine or menthol. Do not use if pouch is damaged or opened.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of Reach of children. If swallowed, get medical help or contact a Poison control Center right away.
Glycerol, Water, Acrylamide/acrylate co-polymer, (Poly) vinyl pyrrolidone, Germaben II
Email info@lidopatch.com
MFG by JAR Laboratories, Elmhurst, IL 60126
NDC 50682 527 03
GET PAIN
RELIEF NOW!
LidoPatch®
CONTAINS LIDOCAINE
PAIN
RELIEF
PATCH
3 TOPICAL PATCHES PER BOX

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1249758 | lidocaine 4 % / menthol 1 % Medicated Patch | PSN | 1 |
| 1249763 | LidoPatch 4 % / 1 % Medicated Patch | PSN | 1 |
| 1249763 | lidocaine 0.04 MG/MG / menthol 0.01 MG/MG Medicated Patch [Lidopatch] | SBD | 1 |
| 1249758 | lidocaine 0.04 MG/MG / menthol 0.01 MG/MG Medicated Patch | SCD | 1 |
| 1249758 | lidocaine 4 % / menthol 1 % Medicated Patch | SY | 1 |
| 1249763 | LidoPatch (lidocaine 4 % / menthol 1 % ) Medicated Patch | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50682-527-03 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b909-f6ea-e053-dbdaa90aa703 | LidoPatch™ |
| 50682-527-07 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b909-f6ea-e053-dbdaa90aa703 | LidoPatch™ |
| 50682-527-30 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b909-f6ea-e053-dbdaa90aa703 | LidoPatch™ |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50682-527-03 | LidoPatchPain Relief | 1 in 1 POUCH | PATCH | 1 | 1 | |
| 50682-527-03 | LidoPatchPain Relief | 3 in 1 CARTON | PATCH | 3 | 1 | |
| 50682-527-07 | LidoPatchPain Relief | 7 in 1 CARTON | PATCH | 7 | 1 | |
| 50682-527-07 | LidoPatchPain Relief | 1 in 1 POUCH | PATCH | 1 | 1 | |
| 50682-527-30 | LidoPatchPain Relief | 30 in 1 CARTON | PATCH | 30 | 1 | |
| 50682-527-30 | LidoPatchPain Relief | 1 in 1 POUCH | PATCH | 1 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| lidocaine | ACTIVE INGREDIENT | 98PI200987 | 1 | |
| menthol | ACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| lidocaine | ACTIVE MOIETY | 98PI200987 | 1 | |
| menthol | ACTIVE MOIETY | L7T10EIP3A | 1 | |
| Acrylamide | INACTIVE INGREDIENT | 20R035KLCI | 1 | |
| Diazolidinyl Urea | INACTIVE INGREDIENT | H5RIZ3MPW4 | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Urea | INACTIVE INGREDIENT | 8W8T17847W | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50682-527 | 50682-527-03, 50682-527-07, 50682-527-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| lidocaine | 98PI200987 | ACTIB |
| menthol | L7T10EIP3A | ACTIB |
| Glycerin | PDC6A3C0OX | IACT |
| Acrylamide | 20R035KLCI | IACT |
| Diazolidinyl Urea | H5RIZ3MPW4 | IACT |
| Urea | 8W8T17847W | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| Urea | UREA | 8W8T17847W | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| Urea | UREA | 8W8T17847W | INSERT / VAGINAL | 50 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| Urea | UREA | 8W8T17847W | DOUCHE / VAGINAL | 8 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| Urea | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Urea | UREA | 8W8T17847W | CREAM / VAGINAL | 0.64 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Urea | UREA | 8W8T17847W | TABLET, EFFERVESCENT / ORAL | 60 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| Diazolidinyl Urea | DIAZOLIDINYL UREA | H5RIZ3MPW4 | OINTMENT / TOPICAL | 0.1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Urea | UREA | 8W8T17847W | TABLET, COATED / ORAL | 0.02 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| Diazolidinyl Urea | DIAZOLIDINYL UREA | H5RIZ3MPW4 | LOTION / TOPICAL | 3 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dec971e0-6bec-4ae4-aec4-76c8ded82c47 | de85ffbf-c92d-4a5a-8b12-e6525f039ab3 | 2012-03-12 | Warnings | dec971e0-6bec-4ae4-aec4-76c8ded82c47 de85ffbf-c92d-4a5a-8b12-e6525f039ab3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.